144 related articles for article (PubMed ID: 35966286)
1. Immature tertiary lymphoid structure formation was increased in the melanoma tumor microenvironment of
Yin S; Zhang C; Gao F
Transl Cancer Res; 2022 Jul; 11(7):2388-2397. PubMed ID: 35966286
[TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous inflammation in the Ikaros Family Zinc Finger 1-keratin 5-specific transgenic mice.
Ueta M; Hamuro J; Nishigaki H; Nakamura N; Shinomiya K; Mizushima K; Hitomi Y; Tamagawa-Mineoka R; Yokoi N; Naito Y; Tokunaga K; Katoh N; Sotozono C; Kinoshita S
Allergy; 2018 Feb; 73(2):395-404. PubMed ID: 28914974
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
Front Immunol; 2021; 12():629519. PubMed ID: 33746966
[TBL] [Abstract][Full Text] [Related]
4. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
5. Turning Tertiary Lymphoid Structures (TLS) into Hot Spots: Values of TLS in Gastrointestinal Tumors.
Cai D; Yu H; Wang X; Mao Y; Liang M; Lu X; Shen X; Guan W
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672316
[TBL] [Abstract][Full Text] [Related]
6. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
Deguchi S; Tanaka H; Suzuki S; Natsuki S; Mori T; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
BMC Cancer; 2022 Jun; 22(1):699. PubMed ID: 35751038
[TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structure and B-cell-related pathways: A potential target in tumor immunotherapy.
Qin M; Jin Y; Pan LY
Oncol Lett; 2021 Dec; 22(6):836. PubMed ID: 34712360
[TBL] [Abstract][Full Text] [Related]
10. [Interleukin-12 over-expression in malignant melanoma B16 cells reduces programmed death-1 expression on T cells in mice with immune reconstitution].
Liu Y; Xu H; Lai N; Yang Z; Kang S
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):856-863. PubMed ID: 32895201
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of Tertiary Lymphoid Structures in Murine Melanoma.
Rodriguez AB; Peske JD; Engelhard VH
Methods Mol Biol; 2018; 1845():241-257. PubMed ID: 30141017
[TBL] [Abstract][Full Text] [Related]
12. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance.
Vitanza NA; Zaky W; Blum R; Meyer JA; Wang J; Bhatla T; Morrison DJ; Raetz EA; Carroll WL
Pediatr Blood Cancer; 2014 Oct; 61(10):1779-85. PubMed ID: 24976218
[TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures in the era of cancer immunotherapy.
Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of PEG10 transgenic mouse and effects of PEG10 on growth, metastasis of transplanted tumor in mice].
Liu Y; Lin JS; Zheng XM; Tan JQ; Wang ZJ; Zhang Q; Wu W; Chang Y
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):455-8. PubMed ID: 19567027
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the Ikzf1 locus.
Yoshida T; Landhuis E; Dose M; Hazan I; Zhang J; Naito T; Jackson AF; Wu J; Perotti EA; Kaufmann C; Gounari F; Morgan BA; Georgopoulos K
Blood; 2013 Oct; 122(18):3149-59. PubMed ID: 24002445
[TBL] [Abstract][Full Text] [Related]
17. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
Ding GY; Ma JQ; Yun JP; Chen X; Ling Y; Zhang S; Shi JY; Chang YQ; Ji Y; Wang XY; Tan WM; Yuan KF; Yan B; Zhang XM; Liang F; Zhou J; Fan J; Zeng Y; Cai MY; Gao Q
J Hepatol; 2022 Mar; 76(3):608-618. PubMed ID: 34793865
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
19. The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.
Mougiakakos D; Bach C; Böttcher M; Beier F; Röhner L; Stoll A; Rehli M; Gebhard C; Lischer C; Eberhardt M; Vera J; Büttner-Herold M; Bitterer K; Balzer H; Leffler M; Jitschin S; Hundemer M; Awwad MHS; Busch M; Stenger S; Völkl S; Schütz C; Krönke J; Mackensen A; Bruns H
Cancer Immunol Res; 2021 Mar; 9(3):265-278. PubMed ID: 33563611
[TBL] [Abstract][Full Text] [Related]
20. IMiD compounds affect CD34
Li S; Fu J; Wang H; Ma H; Xu X; Yang YG; Deng S; Mapara MY; Lentzsch S
Blood Adv; 2018 Mar; 2(5):492-504. PubMed ID: 29496670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
